1
404
R. Kumar et al.
LETTER
NMR (300 MHz, CDCl ): d = 7.66–7.63 (m, 1 H), 7.45–7.39 (m, 3
H), 7.25–7.14 (m, 5 H), 4.26 (s, 2 H). C NMR (75 MHz, CDCl3):
(9) (a) Heynderickx, A.; Guglielmetti, R.; Dubest, R.; Aubard,
J.; Samat, A. Synthesis 2003, 1112. (b) Organic
3
1
3
d = 162.87, 150.84, 140.93, 134.23, 130.29, 128.94, 127.11,
Photochromes; El’tsov, A. V., Ed.; Plenum Press: New
York, 1990, 178.
1
24.96, 124.23, 119.84, 110.40, 31.54. MS: m/z = 242 [M + 1].
Anal. Calcd for C H NOS: C, 69.68; H, 4.59; N, 5.80, S, 13.29.
Found: C, 69.66; H, 4.61; N, 5.81, S, 13.28.
(10) (a) Heathcock, C. H. In Comprehensive Organic Synthesis,
Vol. 2; Trost, B. M.; Flemming, I., Eds.; Pergamon Press:
New York, 1991. (b) Reser, A.; Leyshon, L. J.; Saunders,
D.; Mijovic, M. V.; Bright, A.; Bogie, J. J. Am. Chem. Soc.
1
4
11
2
-(1-Naphthalenylmethyl)benzoxazole (Table 2, entry 12): IR
–
1 1
(neat): 3049, 2923, 1613, 1567, 1455, 1241, 1143, 801 cm . H
1972, 94, 2414.
NMR (300 MHz, CDCl ): d = 8.16–8.13 (m, 1 H), 7.83–7.76 (m, 2
3
(
11) (a) Cohen, V. I.; Pourabass, S. J. Heterocycl. Chem. 1977,
14, 1321. (b) Cohen, V. I. J. Heterocycl. Chem. 1979, 16, 13.
12) (a) Chen, C.; Chen, Y.-J. Tetrahedron Lett. 2004, 45, 113.
H), 7.68–7.64 (m, 1 H), 7.52–7.35 (m, 5 H), 7.25–7.16 (m, 2 H),
.66 (s, 2 H). 1 C NMR (75 MHz, CDCl ): d = 165.03, 150.84,
41.23, 133.79, 131.77, 130.84, 128.66, 128.24, 127.66, 126.44,
25.77, 125.46, 125.15, 124.05, 123.63, 119.68, 110.35, 32.86. MS:
3
4
1
1
3
(
(
b) Nadaf, R. N.; Siddiqui, S. A.; Daniel, T.; Lahoti, R. J.;
Srinivasan, K. V. J. Mol. Catal. A: Chem. 2004, 214, 155.
c) Pottorf, R. S.; Chadha, N. K.; Katevics, M.; Ozola, V.;
m/z = 260 [M + 1]. Anal. Calcd for C H NO: C, 83.37; H, 5.05; N,
1
8
13
(
5
.40. Found: C, 83.35; H, 5.04; N, 5.38.
Suna, E.; Ghane, H.; Regberg, T.; Player, M. R. Tetrahedron
Lett. 2003, 44, 175.
2
-(2-Naphthalenylmethyl)benzoxazole (Table 2, entry 14): IR
–
1
(
neat): 3054, 2924, 1614, 1568, 1455, 1241, 1142, 837, 817 cm .
(13) Tauer, E.; Grellmann, K. H. J. Org. Chem. 1981, 46, 4252.
1
H NMR (300 MHz, CDCl ): d = 7.78–7.74 (m, 4 H), 7.70–7.68 (m,
3
(14) (a) Kawashita, Y.; Nakamichi, N.; Kawabata, H.; Hayashi,
M. Org. Lett. 2003, 5, 3713; and references therein.
1
3
1
H), 7.47–7.39 (m, 4 H), 7.25–7.21 (m, 2 H), 4.37 (s, 2 H). C
NMR (75 MHz, CDCl ): d = 165.00, 150.90, 141.23, 133.36,
3
(b) Wilfred, C. D.; Taylor, R. K. J. Synlett 2004, 1628.
1
1
32.40, 132.06, 128.41, 127.59, 126.81, 126.12, 125.79, 124.58,
24.07, 119.70, 110.31, 35.24. MS: m/z = 260 [M + 1)]. Anal. Calcd
(
1
c) Bougrin, K.; Loupy, A.; Soufiaoudi, M. Tetrahedron
998, 54, 8055.
for C H NO: C, 83.37; H, 5.05; N, 5.40. Found: C, 83.35; H, 5.03;
1
8
13
(15) Park, M. S.; Jun, K.; Shin, S. R.; Oh, S. W.; Park, K. H. J.
Heterocycl. Chem. 2002, 39, 1279; and references therein.
N, 5.43.
(
16) (a) El-Sheikh, M. I.; Marks, A.; Biehl, E. R. J. Org. Chem.
981, 46, 3256. (b) Park, Y.-T.; Jung, C.-H.; Kim, K.-W. J.
1
References
Org. Chem. 1999, 64, 8546.
(
(
(
17) Wang, F.; Hauske, J. R. Tetrahedron Lett. 1997, 37, 6529.
18) DeLuca, M. R.; Kerwin, S. M. Tetrahedron 1997, 53, 457.
19) Shimada, T.; Yamamoto, Y. J. Am. Chem. Soc. 2003, 125,
(
1) Sun, L.-Q.; Chen, J.; Bruce, M.; Deskus, J. A.; Epperson, J.
R.; Takaki, K.; Johnson, G.; Iben, L.; Mahle, C. D.; Ryan, E.;
Xu, C. Bioorg. Med. Chem. Lett. 2004, 14, 3799; and
references therein.
2) Gong, B.; Hong, F.; Kohm, C.; Bonham, L.; Klein, P.
Bioorg. Med. Chem. Lett. 2004, 14, 1455.
6646.
(
(
(
20) Kiselyov, A. S. Tetrahedron Lett. 1999, 40, 4119.
21) Zificsak, C. A.; Hlasta, D. J. Tetrahedron 2004, 60, 8991.
22) (a) Heine, D. W.; Alheim, R. J.; Leavitt, J. J. J. Am. Chem.
Soc. 1957, 79, 427. (b) Knaoka, Y.; Hamada, T.;
(
(
(
(
3) Paramshivappa, R.; Kumar, P. P.; Subba Rao, P. V.;
Srinivasa Rao, A. Bioorg. Med. Chem. Lett. 2003, 13, 657.
4) Kumar, D.; Jacob, M. R.; Reynolds, M. B.; Kerwin, S. M.
Bioorg. Med. Chem. 2002, 10, 3997.
Yonemitsu, O. Chem. Pharm. Bull. 1970, 18, 587.
(
(
23) Terashima, M.; Ishii, M.; Kanaoka, Y. Synthesis 1982, 484.
24) Cho, C. S.; Kim, D. T.; Zhang, J. Q.; Ho, S.-L.; Kim, T.-J.;
Shim, S. C. J. Heterocycl. Chem. 2002, 39, 421.
5) López-Tudanca, P. L.; Labeaga, L.; Innerárity, A.; Alonso-
Cires, L.; Tapia, I.; Mosquera, R.; Orjales, A. Bioorg. Med.
Chem. 2003, 11, 2709.
(
(
25) Lidstorm, P.; Tierney, J.; Wathey, B.; Westman, J.
Tetrahedron 2001, 54, 9225.
(6) (a) Kočí, J.; Klimešová, V.; Waisser, K.; Kaustová, J.;
26) (a) Yildiz-Oren, I.; Yalcin, I.; Aki-Sener, E.; Ucarturk, N.
Eur. J. Med. Chem. 2004, 39, 291. (b) Verma, M.; Tripathi,
M.; Saxena, A. K.; Shanker, K. Eur. J. Med. Chem. 1994, 29,
Dahse, H.-M.; Möllmann, U. Bioorg. Med. Chem. Lett.
2002, 12, 3275. (b) Temiz, Ö.; Ören, I.; Şener, E.; Yalçin, I.;
Uçarturk, N. Il Farmaco 1998, 53, 337; and references cited
therein.
941. (c) Yalcin, ; Ören, ; Sener, E.; Akin, A.; Ucartürk, N.
Eur. J. Med. Chem. 1992, 27, 401.
(
(
7) Edwards, P. D.; Meyer, E. F.; Vijayalakshmi, J.; Tuthill, P.
A.; Andisik, D. A.; Gomes, B.; Strimpler, A. J. Am. Chem.
Soc. 1992, 114, 1854.
(
27) The work cited under ref. 14c deals with only three examples
of benzoxazole formation by microwave-assisted
condensation of aromatic carboxylic acids with 2-
aminophenol.
8) Lin, L. S.; Lanza, T. J. Jr.; Castonguay, L. A.; Kamenecka,
T.; McCauley, E.; Riper, G. V.; Egger, L. A.; Mumford, R.
A.; Tong, X.; MacCoss, M.; Schmidt, J. A.; Hagmann, W. K.
Bioorg. Med. Chem. Lett. 2004, 14, 2331.
(
28) Garrett, R. L. In Designing Safer Chemicals; Garrett, R. L.;
De Vito, S. C., Eds.; American Chemical Society
Symposium Series 640: Washington DC, 1996, Chap. 1.
Synlett 2005, No. 9, 1401–1404 © Thieme Stuttgart · New York